Market Overview:
The global polymyxin E market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising demand for polymyxin E in animal feed, increasing awareness about the benefits of using polymyxin E, and growing demand for antibiotic-free meat products. However, stringent regulatory norms and high cost of production are some of the major factors restraining the growth of this market. On the basis of type, API accounted for a majority share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its widespread use as an antibiotic agent across various applications.
Product Definition:
Polymyxin E is a polypeptide antibiotic with a spectrum of activity similar to that of polymyxin B. It is used to treat infections caused by susceptible gram-negative bacteria, including Pseudomonas aeruginosa.
API:
API (Application Programming Interface) is a set of defined rules for communication between software and hardware. Polymyxin E, also known as PME or polymyxin, is an antibiotic used in the treatment of bacterial infections including pneumonia. It works by killing the bacteria cells. The drug has been approved for use in humans and animals but its main application has been veterinary medicine to treat respiratory diseases such as tuberculosis and pneumonia caused due to susceptible strains of pneumococcal disease among others.
Premix:
The global polymyxin e market size was valued at USD 8.5 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period on account of rising demand from hospitals, nursing homes, and long-term care centers.
Application Insights:
On the basis of application, the global polymyxin e market has been segmented into pig, chicken and other animals. Polymyxin is a water-soluble antibiotic that is used for various animal health issues including respiratory diseases caused due to pneumonia or bronchitis in pigs as well as chickens. The other animals category includes dogs and cats.
The pig segment held around 40% of the overall share in terms of demand and this trend is expected to continue over the forecast period owing to increasing production volumes coupled with high consumption rates among Asian countries such as China Japan India Indonesia Malaysia Philippines Singapore Thailand Vietnam etc. These countries are major producers of pork products which are consumed by people from both urban and rural areas thus fueling demand for antibiotics such as polymyxin E over there.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and accounted for a revenue share of over 40%. The region is expected to maintain its dominance throughout the forecast period owing to high product demand from countries, such as China, India, Japan, and South Korea. Increasing meat consumption in these countries coupled with rising concerns regarding food safety is likely to have a positive impact on industry growth.
The Asia Pacific polymyxin E market by application is segmented into Respiratory Infections (ARI), Urinary Tract Infection (UTI), Carbuncles & Cellulites (C&C) Diseases. UTIs are highly prevalent among Asian population owing to unhealthy lifestyle choices and lack of proper hygiene leading factors contributing towards high demand for polymyxin E in this region.
Growth Factors:
- Increasing incidence of antibiotic-resistant bacterial infections: The increasing incidence of antibiotic-resistant bacterial infections is a major growth driver for the polymyxin E market. Polymyxins are one of the last resort antibiotics for treating such infections and hence, their demand is expected to rise in the coming years.
- Rising prevalence of hospital-acquired infections (HAIs): The rising prevalence of HAIs is another key factor driving the growth of the polymyxin E market. Polymyxins are extensively used to treat HAIs and their demand is expected to surge in the coming years as hospitals become increasingly aware about their benefits over other antibiotics.
- Growing number of clinical trials evaluating polymyxins: A growing number of clinical trials evaluating different formulations and combinations containing polymyxins are being conducted across regions, which is likely to boost market growth in the near future. This will increase awareness about these drugs among healthcare professionals and patients alike, thereby propelling demand for them globally.
- . 5 Emerging markets offer high potentialgrowth opportunities: Emerging markets such as Chinaand Indiaoffer high potentialgrowth opportunities
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymyxin E Market Research Report
By Type
API, Premix, Others
By Application
Pig, Chicken, Other
By Companies
Shengxue Dacheng, Apeloa, Livzon Group, LKPC, Xellia, Shenghua Biok, Qianjiang Biochemical, Lifecome
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Polymyxin E Market Report Segments:
The global Polymyxin E market is segmented on the basis of:
Types
API, Premix, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pig, Chicken, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shengxue Dacheng
- Apeloa
- Livzon Group
- LKPC
- Xellia
- Shenghua Biok
- Qianjiang Biochemical
- Lifecome
Highlights of The Polymyxin E Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- API
- Premix
- Others
- By Application:
- Pig
- Chicken
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymyxin E Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polymyxin E is a type of antibiotic. It works by killing bacteria.
Some of the key players operating in the polymyxin e market are Shengxue Dacheng, Apeloa, Livzon Group, LKPC, Xellia, Shenghua Biok, Qianjiang Biochemical, Lifecome.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Polymyxin E Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Polymyxin E Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Polymyxin E Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Polymyxin E Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Polymyxin E Market Size & Forecast, 2020-2028
4.5.1 Polymyxin E Market Size and Y-o-Y Growth
4.5.2 Polymyxin E Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 API
5.2.2 Premix
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pig
6.2.2 Chicken
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Polymyxin E Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Polymyxin E Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 API
9.6.2 Premix
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pig
9.10.2 Chicken
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 API
10.6.2 Premix
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pig
10.10.2 Chicken
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 API
11.6.2 Premix
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pig
11.10.2 Chicken
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 API
12.6.2 Premix
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pig
12.10.2 Chicken
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 API
13.6.2 Premix
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pig
13.10.2 Chicken
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Polymyxin E Market: Competitive Dashboard
14.2 Global Polymyxin E Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Shengxue Dacheng
14.3.2 Apeloa
14.3.3 Livzon Group
14.3.4 LKPC
14.3.5 Xellia
14.3.6 Shenghua Biok
14.3.7 Qianjiang Biochemical
14.3.8 Lifecome
